ES516390A0 - Un procedimiento para la preparacion de un nuevo peptido activo. - Google Patents

Un procedimiento para la preparacion de un nuevo peptido activo.

Info

Publication number
ES516390A0
ES516390A0 ES516390A ES516390A ES516390A0 ES 516390 A0 ES516390 A0 ES 516390A0 ES 516390 A ES516390 A ES 516390A ES 516390 A ES516390 A ES 516390A ES 516390 A0 ES516390 A0 ES 516390A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
active peptide
new active
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES516390A
Other languages
English (en)
Other versions
ES8400397A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of ES8400397A1 publication Critical patent/ES8400397A1/es
Publication of ES516390A0 publication Critical patent/ES516390A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES516390A 1980-12-01 1982-10-08 Un procedimiento para la preparacion de un nuevo peptido activo. Granted ES516390A0 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB8038509 1980-12-01
GB8102687 1981-01-29
GB8111584 1981-04-13

Publications (2)

Publication Number Publication Date
ES8400397A1 ES8400397A1 (es) 1983-11-01
ES516390A0 true ES516390A0 (es) 1983-11-01

Family

ID=27261059

Family Applications (2)

Application Number Title Priority Date Filing Date
ES507630A Granted ES507630A0 (es) 1980-12-01 1981-12-01 Un procedimiento para la preparacion de un nuevo reptido activo.
ES516390A Granted ES516390A0 (es) 1980-12-01 1982-10-08 Un procedimiento para la preparacion de un nuevo peptido activo.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES507630A Granted ES507630A0 (es) 1980-12-01 1981-12-01 Un procedimiento para la preparacion de un nuevo reptido activo.

Country Status (8)

Country Link
EP (1) EP0053388B1 (es)
AU (1) AU7813681A (es)
CA (1) CA1247083A (es)
DE (1) DE3172076D1 (es)
DK (1) DK521981A (es)
ES (2) ES507630A0 (es)
GR (1) GR81332B (es)
HU (1) HU188110B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4565653A (en) * 1984-03-30 1986-01-21 Pfizer Inc. Acyltripeptide immunostimulants
US4619915A (en) * 1984-10-19 1986-10-28 Pfizer Inc. Peptide-substituted heterocyclic immunostimulants
US4851388A (en) * 1986-01-23 1989-07-25 Pfizer Inc. Heptanoyl-glu-asp-ala-amino acid immunostimulants

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2033906B (en) * 1978-10-19 1982-12-01 Anvar Water-soluble compounds derived from extracts of streptomyces stimulosus process for their production and compositions containing them
DE2963446D1 (en) * 1978-11-14 1982-09-16 Fujisawa Pharmaceutical Co New lactyl tetrapeptide, processes for preparation thereof and pharmaceutical compositions containing it
FR2460290A1 (fr) * 1979-06-29 1981-01-23 Rhone Poulenc Ind Nouveaux tetra- ou pentapeptides, leur preparation et les medicaments qui les contiennent
DK156252C (da) * 1979-07-31 1989-12-18 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af di-, tri- eller tetrapeptidderivater eller salte deraf
EP0027260B1 (en) * 1979-10-11 1985-03-13 Fujisawa Pharmaceutical Co., Ltd. Peptides, processes for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
CA1247083A (en) 1988-12-20
EP0053388B1 (en) 1985-08-28
DE3172076D1 (en) 1985-10-03
HU188110B (en) 1986-03-28
ES8303297A1 (es) 1983-02-01
ES507630A0 (es) 1983-02-01
DK521981A (da) 1982-06-02
ES8400397A1 (es) 1983-11-01
GR81332B (es) 1984-12-11
AU7813681A (en) 1982-06-10
EP0053388A1 (en) 1982-06-09

Similar Documents

Publication Publication Date Title
ES548388A0 (es) Un procedimiento para la preparacion de un peptido.
ES504905A0 (es) Un procedimiento para la preparacion de una nueva formulacion de bacampicilina.
ES528628A0 (es) Un procedimiento para la preparacion de pirazolo y piridazo-pirazolinas, piridazinas y diazepinas.
ES521435A0 (es) Un procedimiento para la preparacion de quinolizidinil benzamidas.
ES506969A0 (es) Un procedimiento para la preparacion de pirimidinas sustitu-idas.
ES505464A0 (es) Un procedimiento para la preparacion de n-heterociclilaminocarbonil arilsulfonamidas.
ES520730A0 (es) Un procedimiento para la prepracion de nuevas benzolactamas.
ES507507A0 (es) Un procedimiento para la pre-paracion de imidazolilfenilami-dinas.
ES503307A0 (es) Un procedimiento para la preparacion de quinoxaliniloxieteres.
ES515158A0 (es) Un procedimiento para la preparacion de 2-guanidino-4-heteroariltiazoles.
ES522940A0 (es) Un procedimiento para la preparacion de nuevos benzamidas.
ES523807A0 (es) Un procedimiento para la preparacion de nuevas benzamidas.
ES503878A0 (es) Un procedimiento para la preparacion de un derivado cis-4,5-disustituidos de imidazolidin-2-ona opticamente activo.
ES509787A0 (es) "un procedimiento para preparar un peptido".
ES535727A0 (es) Un procedimiento para la preparacion de nuevos peptidos.
ES503169A0 (es) Un procedimiento para la preparacion de tiofen-sulfonamidas con actividad insecticida.
ES498945A0 (es) Un procedimiento para la preparacion de benzamidas.
ES522559A0 (es) Un procedimiento para la preparacion de un derivado de un peptido ciclico a-21978c.
ES516390A0 (es) Un procedimiento para la preparacion de un nuevo peptido activo.
ES503549A0 (es) Procedimiento para la preparacion de un nuevo copolimero de acrimolitrilo y - metilestineno.
ES527780A0 (es) Un procedimiento para la preparacion de nuevas espiro-3-azolindionas.
ES507919A0 (es) Un procedimiento para la preparacion de benzopiranotriazoles antialergicos.
ES508467A0 (es) Un procedimiento para la preparacion de un peptido.
ES514335A0 (es) Un procedimiento para la preparacion de guanidinas.
ES521773A0 (es) Un procedimiento para la preparacion de nuevas benzamidas.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20040601